Search results
Results From The WOW.Com Content Network
The Journal of the National Comprehensive Cancer Network, established in 2003, is a monthly peer-reviewed medical journal of oncology and the official journal of the National Comprehensive Cancer Network (NCCN). It is published by Harborside Press and the editor-in-chief is Margaret Tempero (UCSF Helen Diller Family Comprehensive Cancer Center ...
"The National Comprehensive Cancer Network (NCCN)". J Med Libr Assoc. 92 (3): 382– 3. PMC 442186. "New developments from National Comprehensive Cancer Network (NCCN) outlined recently" Physician Law Weekly August 1, 2007 "New Guidelines Updates from National Comprehensive Cancer Network"Cancerwatch Online (March 2004) 13(3)
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Help; Learn to edit; Community portal; Recent changes; Upload file
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
NGC Guideline Syntheses often provide a comparison of guidelines developed in different countries, providing insight into commonalities and differences in international health practices. An electronic forum, NGC-L for exchanging information on clinical practice guidelines, their development, implementation and use
The California Digital Library (CDL) is the eleventh library for the University of California (UC). A collaborative effort of the ten campuses, organizationally housed at the University of California Office of the President, it is responsible for the design, creation, and implementation of systems that support the shared collections of the University of California.
The EQUATOR Network developed and maintains a comprehensive library that provides a collection of publications related to reporting guidelines on scientific writing, empirical evidence supporting or refuting the inclusion of crucial items in reporting guidelines, evaluations of the quality of reporting, publication ethics and educational materials and tools for editors, peer reviewers and ...
The NCCN Panel considers the 21-gene assay as an option when evaluating certain tumors [39] to assist in estimating likelihood of recurrence and benefit from chemotherapy, emphasizing that the recurrence score should be used along with other breast cancer classification elements when stratifying risk. [39]